Immunopathology & Immunotherapy
10.4K views | +0 today
Follow
Immunopathology & Immunotherapy
Latest advances in immunopathology diagnosis and treatment
Curated by Alfredo Corell
Your new post is loading...
Your new post is loading...
Scooped by Alfredo Corell
Scoop.it!

The pathogenesis of systemic lupus erythematosus—an update-Current Opinion in Immunology -

The pathogenesis of systemic lupus erythematosus—an update-Current Opinion in Immunology - | Immunopathology & Immunotherapy | Scoop.it

The pathogenesis of systemic lupus erythematosus—an update

Jinyoung Choi1, *,Sang Taek Kim1, *,Joe Craft1, 2,

1 Department of Internal Medicine (Rheumatology), Yale School of Medicine, New Haven, CT 06520, United States2 Department of Immunobiology, Yale School of Medicine, New Haven, CT 06520, United States

http://dx.doi.org/10.1016/j.coi.2012.10.004,

 

Systemic lupus erythematosus (SLE, lupus) is characterized by a global loss of self-tolerance with activation of autoreactive T and B cells leading to production of pathogenic autoantibodies and tissue injury. Innate immune mechanisms are necessary for the aberrant adaptive immune responses in SLE. Recent advances in basic and clinical biology have shed new light on disease mechanisms in lupus, with this review discussing the recent studies that offer valuable insights into disease-specific therapeutic targets.

 

The pathogenesis of systemic lupus erythematosus—an update [Current Opinion in Immunology—an update] http://t.co/gKMERgRK...

Gilbert C FAURE's comment, August 17, 2013 11:26 AM
november 2012, a synthetic review of uptodate hypothesis
Scooped by Alfredo Corell
Scoop.it!

Targeting Cancer with a Lupus Autoantibody - Sci Transl Med 24 October 2012

Targeting Cancer with a Lupus Autoantibody - Sci Transl Med 24 October 2012 | Immunopathology & Immunotherapy | Scoop.it

Sci Transl Med 24 October 2012:
Vol. 4, Issue 157, p. 157ra142
Sci. Transl. Med. DOI: 10.1126/scitranslmed.3004385

 

CancerTargeting Cancer with a Lupus Autoantibody

this study provides the basis for the potential use of a lupus anti-DNA antibody in cancer therapy and identifies lupus autoantibodies as a potentially rich source of therapeutic agents.

 

James E. Hansen1,2,*,Grace Chan3,Yanfeng Liu1,Denise C. Hegan1,Shibani Dalal1,Eloise Dray4,†,Youngho Kwon4,Yuanyuan Xu4,Xiaohua Xu5,Elizabeth Peterson-Roth1,Erik Geiger1,Yilun Liu5,Joseph Gera3,6,Joann B. Sweasy1,2,7,8,Patrick Sung1,2,4,Sara Rockwell1,2,9,Robert N. Nishimura3,10,Richard H. Weisbart3 andPeter M. Glazer1,2,8,*

 

See also a summary in the news:

http://www.voanews.com/content/autoimmune-disease-antibodies-help-fight-cancer/1533596.html?goback=.gde_151241_member_179119923

 

 

No comment yet.